- 询价
- Signalway Antibody
- 48095
- 2025年09月23日
- WB, ICC, FC
- Mouse
- Human
企业认证
相关产品推荐更多 >
![MEK-1/2 (phospho-Ser218/222) Polyclonal Antibody[13716]](https://img1.dxycdn.com/p/s14/2025/0922/498/0460884283108299691.jpg!wh200)
![Keratin 20 Conjugated Antibody[C33418]](https://img1.dxycdn.com/p/s14/2025/0923/278/4431488150116040791.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
recombinant protein
- 形态：
liquid
- 保存条件：
Store at -20˚C
- 克隆性：
Monoclonal
- 适应物种：
Human
- 保质期：
12 months
- 抗原来源：
Mouse
- 供应商：
南京赛戈巍生物科技有限公司
- 宿主：
Mouse
- 应用范围：
WB, ICC, FC
- 靶点：
Uniprot：P08505
- 抗体英文名：
Interleukin 6 Antibody
- 规格：
50ul/100ul
B cell differentiation factor antibody
B cell stimulatory factor 2 antibody
B-cell stimulatory factor 2 antibody
BSF 2 antibody
BSF-2 antibody
BSF2 antibody
CDF antibody
CTL differentiation factor antibody
Hepatocyte stimulatory factor antibody
HGF antibody
HSF antibody
Hybridoma growth factor antibody
Hybridoma growth factor Interferon beta-2 antibody
IFN-beta-2 antibody
IFNB2 antibody
IL 6 antibody
IL-6 antibody
IL6 antibody
IL6_HUMAN antibody
Interferon beta 2 antibody
Interferon beta-2 antibody
Interleukin 6 antibody
Interleukin 6 (interferon beta 2) antibody
Interleukin BSF 2 antibody
Interleukin-6 antibody
计算分子量:24kDa
配方:1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
应用详情:WB: 1:10,000
IP:1:1,000
图片:
Western blot analysis on bioactive mouse IL-6 protein using anti-IL-6 Mouse mAb (Cat. # M1303-3).
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验A Microchip-Based Assay for Interleukin-6
” system, with its selectivity determined by the specificity of the antibody that it hosts. The bead-loaded chip is sandwiched between two optically transparent polymethylmethacrylate inserts, packaged within a metal casing described here as the “flow cell.” This flow cell
cell destruction by effector cells with Fc receptors such as natural killer (NK) cells and macrophages. These cells recognize the mAb binding to the tumor cells and mediate antibody-dependent cellular cytotoxicity (ADCC). Enhanced ADCC is mediated
Antibody-Cytokine Fusion Proteins for the Therapy of Cancer
In recent years the development of tumor-specific recombinant antibodies fused to immunostimulatory cytokines such as interleukin-2 (IL-2), interleukin-12 (IL-12), and granulocyte/mac rophage colony-stimulating factor (GM-CSF) has provided
技术资料暂无技术资料 索取技术资料
